BioNTech And Pfizer Want CureVac COVID Patents Nixed
BioNTech and Pfizer have asked a London court to invalidate two European patents for a rival's COVID-19 vaccine technology, bringing an international patent spat between the companies to the U.K....To view the full article, register now.
Already a subscriber? Click here to view full article